Search

TMP21 in Alzheimer’s Disease: An Important Target For Effective Treatment Approach

Ebook: Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815136142123010006

Neuro-inflammatory Responses in Alzheimer’s v/s Parkinson’s Diseases

Ebook: Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases
Volume: 1 Year: 2024
Author(s):
Doi: 10.2174/9789815238754124010005

Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia

Journal: Current Neuropharmacology
Volume: 18 Issue: 1 Year: 2020 Page: 2-13
Author(s): Michal Rychlik,Katarzyna Mlyniec

Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 5 Year: 2011 Page: 621-634
Author(s): Vincenzo Pizza, Anella Agresta, Cosimo W. DAcunto, Michela Festa, Anna Capasso

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease

Journal: Current Neuropharmacology
Volume: 10 Issue: 3 Year: 2012 Page: 272-285
Author(s): Yu-Jhen Huang,Chieh-Hsin Lin,Hsien-Yuan Lane,Guochuan E. Tsaid

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 6 Year: 2013 Page: 870-881
Author(s): Marta Sochocka, Euphrosyni S. Koutsouraki, Kazimierz Gasiorowski, Jerzy Leszek

Neurogenic Molecules Modulating Cell Survival Pathways, Amyloid Beta, Tau Proteins, and Metal Dyshomeostasis: An Alternative Hope for Alzheimer’s Therapy

Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 1 Year: 2013
Author(s): Hailin Zheng,Mati Fridkin,Moussa B.H. Youdim
Doi: 10.2174/9781608057221113010009

Tau-Directed Therapies for Alzheimer’s Disease and Other Tauopathies

Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 1 Year: 2013
Author(s): Yasumasa Yoshiyama
Doi: 10.2174/9781608057221113010006